Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Oral Laquinimod for Multiple Sclerosis Treatment Significantly Reduced Disease Activity and Disability Progression While Providing Good Safety and Tolerability
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.
An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination.
CNS vasculitis in a patient with MS on daclizumab monotherapy.
CLIC1 regulates dendritic cell antigen processing and presentation by modulating phagosome acidification and proteolysis.
Measuring participation as defined by the World Health Organization in the International Classification of Functioning, Disability and Health. Psychometric properties of the Ghent Participation Scale.
Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer's disease.
Rare onset symptoms in multiple sclerosis.
Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact.
Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies.
Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells.
AB Science confirms the filing for the Marketing Authorization Application to the European Medicines Agency of masitinib in the treatment of pancreatic cancer
Multiple Sclerosis and Catastrophic Health Expenditure in Iran.
Results from Two Phase III Studies Added to U.S. Label of Genzyme’s Aubagio
Ampyra (Fampyra)
Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.
Leflunomide: mode of action in the treatment of rheumatoid arthritis.
Arginase-1 is expressed exclusively by infiltrating myeloid cells in CNS injury and disease.
Preclinical studies of sex differences: a clinical perspective.
Central fatigue in multiple sclerosis: a review of the literature.
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.
Mechanism of action for leflunomide in rheumatoid arthritis.
Pathogenic implications of iron accumulation in multiple sclerosis.
Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of falling.

Pages